|
US670417A
(en)
|
1899-08-30 |
1901-03-26 |
Cronk Hanger Co |
Hand-rake.
|
|
US3270960A
(en)
|
1964-09-11 |
1966-09-06 |
Sperry Rand Corp |
Fluid sensor
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4609546A
(en)
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US5057313A
(en)
|
1986-02-25 |
1991-10-15 |
The Center For Molecular Medicine And Immunology |
Diagnostic and therapeutic antibody conjugates
|
|
JPS63502716A
(ja)
|
1986-03-07 |
1988-10-13 |
マサチューセッツ・インステチュート・オブ・テクノロジー |
糖タンパク安定性の強化方法
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
DE3889853D1
(de)
|
1987-11-05 |
1994-07-07 |
Hybritech Inc |
Polysaccharidmodifizierte Immunglobuline mit reduziertem immunogenem Potential oder verbesserter Pharmakokinetik.
|
|
US5283187A
(en)
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
|
US4892538A
(en)
|
1987-11-17 |
1990-01-09 |
Brown University Research Foundation |
In vivo delivery of neurotransmitters by implanted, encapsulated cells
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
ATE139900T1
(de)
|
1992-11-13 |
1996-07-15 |
Idec Pharma Corp |
Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
|
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
US5747654A
(en)
|
1993-06-14 |
1998-05-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant disulfide-stabilized polypeptide fragments having binding specificity
|
|
US5443953A
(en)
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
|
DE4343591A1
(de)
|
1993-12-21 |
1995-06-22 |
Evotec Biosystems Gmbh |
Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
|
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
HK1049170A1
(zh)
|
1999-07-30 |
2003-05-02 |
Medarex, Inc. |
包含抗-fc受體粘結劑的治療混合物
|
|
ES2376454T3
(es)
|
2000-12-22 |
2012-03-14 |
Grad, Carole, Legal Representative Of Howard, Kaplan |
Librer�?as de expresión en fago de fragmentos vh humanos.
|
|
US20030022243A1
(en)
|
2001-06-20 |
2003-01-30 |
Les Kondejewski |
Protein aggregation assays and uses thereof
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
JP4583168B2
(ja)
|
2002-06-03 |
2010-11-17 |
ザ インスティテュート フォー システムズ バイオロジー |
糖タンパク質を定量的プロテオ−ム分析する方法
|
|
JP5087274B2
(ja)
|
2003-06-30 |
2012-12-05 |
ドマンティス リミテッド |
ポリペプチド
|
|
EP1740946B1
(en)
|
2004-04-20 |
2013-11-06 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
US7894724B2
(en)
|
2005-03-31 |
2011-02-22 |
Ciena Corporation |
Method and apparatus for improving dual-polarization optical communication performance
|
|
DK1999154T3
(da)
|
2006-03-24 |
2012-12-03 |
Merck Patent Gmbh |
Fremstillede heterodimere proteindomæner
|
|
EP1916257A1
(en)
|
2006-10-27 |
2008-04-30 |
Charite-Universitätsmedizin Berlin |
GD2 peptide mimotopes for anticancer vaccination
|
|
US8313730B2
(en)
|
2006-12-13 |
2012-11-20 |
Michael R. Simon |
Treatment of celiac disease with IgA
|
|
JP5675109B2
(ja)
|
2007-02-20 |
2015-02-25 |
アナプティスバイオ インコーポレイティッド |
ライブラリーの生成方法及びその使用
|
|
GB0812478D0
(en)
|
2008-07-09 |
2008-08-13 |
Rolls Royce Plc |
An apparatus and a method of measuring erosion of an edge of a turbomachine aerofoil
|
|
US10407513B2
(en)
|
2008-09-26 |
2019-09-10 |
Ucb Biopharma Sprl |
Biological products
|
|
AU2015200990B2
(en)
*
|
2009-03-20 |
2016-07-21 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Optimized Fc variants
|
|
WO2010127369A1
(en)
|
2009-05-01 |
2010-11-04 |
Rational Biotechnology Inc. |
Eit (electrical impedance tomography) guided sonoporation, ultrasound tissue ablation and their use thereof
|
|
CN102549016B
(zh)
*
|
2009-06-30 |
2015-05-06 |
研究发展基金会 |
免疫球蛋白fc多肽
|
|
EP2578681B1
(en)
|
2010-05-24 |
2015-07-01 |
Kagoshima University |
Iga-binding peptide and iga purification using same
|
|
CN105859889B
(zh)
*
|
2010-11-17 |
2020-01-07 |
中外制药株式会社 |
具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
|
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
WO2013087914A1
(en)
|
2011-12-16 |
2013-06-20 |
Synthon Biopharmaceuticals B.V. |
EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
CN104254542A
(zh)
|
2012-03-09 |
2014-12-31 |
瑞士杰特贝林生物制品有限公司 |
包含分泌-样免疫球蛋白的组合物
|
|
FI3366705T3
(fi)
*
|
2012-09-12 |
2023-07-28 |
Genzyme Corp |
Muuttuneen glykosylaation ja vähentyneen efektoritoiminnan omaavia fc:n sisältäviä polypeptidejä
|
|
EP2912058A1
(en)
|
2012-10-23 |
2015-09-02 |
The Board of Regents of The University of Texas System |
Antibodies with engineered igg fc domains
|
|
RU2693078C2
(ru)
|
2012-12-03 |
2019-07-01 |
Новиммун С.А. |
Анти-cd47 антитела и способы их применения
|
|
US20150263589A1
(en)
|
2014-03-11 |
2015-09-17 |
Varnell M. Castor |
Rail Barrel Direct Energy Transferor Piezoelectricity (RBDETP)
|
|
WO2015138600A2
(en)
|
2014-03-11 |
2015-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies
|
|
JP6564777B2
(ja)
|
2014-07-18 |
2019-08-21 |
国立感染症研究所長 |
多量体ＩｇＡ型遺伝子組換え抗体を含む組成物及びその利用
|
|
CA3035427A1
(en)
|
2016-09-01 |
2018-03-08 |
Umc Utrecht Holding B.V. |
Cd20 antibodies
|
|
WO2019022600A1
(en)
|
2017-07-24 |
2019-01-31 |
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis |
TREATMENT OF PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPA INTERACTION - CD47
|
|
JP2020534370A
(ja)
*
|
2017-09-21 |
2020-11-26 |
ユーエムセー ユトレヒト ホールディング ベイフェイＵＭＣ Ｕｔｒｅｃｈｔ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． |
神経芽腫の治療のための抗ｇｄ２抗体
|
|
GB2596411B
(en)
*
|
2018-10-29 |
2023-09-20 |
Tigatx Inc |
Compositions and methods comprising IgA antibody constructs
|
|
SG11202107981VA
(en)
|
2019-01-22 |
2021-08-30 |
Genentech Inc |
Immunoglobulin a antibodies and methods of production and use
|
|
CA3131705A1
(en)
*
|
2019-03-27 |
2020-10-01 |
Umc Utrecht Holding B.V. |
Engineered iga antibodies and methods of use
|